Abstract
A series of new halophenols were synthesized, and their structures were established on the basis of 1H, 13C NMR and mass spectral data. All of the prepared compounds were screened for their in vitro protein tyrosine kinase (PTK) and vascular smooth muscle cell (VSMC) proliferation inhibitory activity. Twelve halophenols showed significant PTK inhibitory activity, most of them exhibited stronger activities than that of genistein, a positive reference compound. Several halophenols also displayed moderate VSMC proliferation inhibitory activity, compound 8c showed higher activity than that of tetrandrine, a positive reference compound. The preliminary structure–activity relationships of these compounds were investigated and discussed. The results provided a foundation for the action mechanism study and further structure optimization of the halophenols.
Keywords: Halophenols, furan-2-yl(phenyl)methanone, protein tyrosine kinase (PTK) inhibitor, vascular smooth muscle cell (VSMC) proliferation inhibitor, Structure–activity relationships (SAR)
Medicinal Chemistry
Title:Synthesis and Biological Activities of New Halophenols
Volume: 9 Issue: 2
Author(s): FeiLang Zheng, ShuRong Ban, XiuE Feng, ChengXiao Zhao, GuanHua Du and QingShan Li
Affiliation:
Keywords: Halophenols, furan-2-yl(phenyl)methanone, protein tyrosine kinase (PTK) inhibitor, vascular smooth muscle cell (VSMC) proliferation inhibitor, Structure–activity relationships (SAR)
Abstract: A series of new halophenols were synthesized, and their structures were established on the basis of 1H, 13C NMR and mass spectral data. All of the prepared compounds were screened for their in vitro protein tyrosine kinase (PTK) and vascular smooth muscle cell (VSMC) proliferation inhibitory activity. Twelve halophenols showed significant PTK inhibitory activity, most of them exhibited stronger activities than that of genistein, a positive reference compound. Several halophenols also displayed moderate VSMC proliferation inhibitory activity, compound 8c showed higher activity than that of tetrandrine, a positive reference compound. The preliminary structure–activity relationships of these compounds were investigated and discussed. The results provided a foundation for the action mechanism study and further structure optimization of the halophenols.
Export Options
About this article
Cite this article as:
Zheng FeiLang, Ban ShuRong, Feng XiuE, Zhao ChengXiao, Du GuanHua and Li QingShan, Synthesis and Biological Activities of New Halophenols, Medicinal Chemistry 2013; 9 (2) . https://dx.doi.org/10.2174/1573406411309020013
DOI https://dx.doi.org/10.2174/1573406411309020013 |
Print ISSN 1573-4064 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6638 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
The Role of Natural Products in the Ligand Deorphanization of TRP Channels
Current Pharmaceutical Design Design of New Oxazaphosphorine Anticancer Drugs
Current Pharmaceutical Design A Critical and Comprehensive Insight on Heme Oxygenase and Related Products Including Carbon Monoxide, Bilirubin, Biliverdin and Ferritin in Type-1 and Type-2 Diabetes
Current Pharmaceutical Design Bacteriophages as Therapeutic and Prophylactic Means: Summary of the Soviet and Post Soviet Experiences
Current Drug Delivery Mortality and Morbidity of HIV Infected Patients Receiving HAART: A Cohort Study
Current HIV Research Serotonergic System and Its Role in Epilepsy and Neuropathic Pain Treatment: A Review Based on Receptor Ligands
Current Pharmaceutical Design Biologically Active Antimicrobial Compounds from Marine Microorganisms (2005-2019)
Current Pharmaceutical Biotechnology Stem Cell and Gene Therapeutic Strategies for the Treatment of Multiple Sclerosis
Current Molecular Medicine Progression of Alzheimer-type Neurofibrillary Tangles is Related to the Proximodistal Segments of the Hemispheric Arteries
Current Alzheimer Research Transcriptional Regulation of Antimicrobial Host Defense Peptides
Current Protein & Peptide Science Computational Biology Tools for Identifying Specific Ligand Binding Residues for Novel Agrochemical and Drug Design
Current Protein & Peptide Science Antifungal Agents in Hematopoietic Stem Cell Transplantation
Current Pharmaceutical Design Designing Promiscuous Drugs? Look at What Nature Made!
Letters in Drug Design & Discovery Mucopolysaccharidosis Type III (Sanfilippo Syndrome): Emerging Treatment Strategies
Current Pharmaceutical Biotechnology Antibodies as Anti-Infective Agents in Medicinal Chemistry
Anti-Infective Agents in Medicinal Chemistry Recent Developments in Therapeutic Approaches for Lysosomal Storage Diseases
Recent Patents on CNS Drug Discovery (Discontinued) Design and Optimization of Itraconazole Loaded SLN for Intranasal Administration Using Central Composite Design
Nanoscience & Nanotechnology-Asia The Updated Role of the Blood Brain Barrier in Subarachnoid Hemorrhage: From Basic and Clinical Studies
Current Neuropharmacology Molecular Docking Study of a Series of Substituted Xanthone Derivatives as Novel COX-2 Inhibitors Targeting Prostaglandin Endoperoxide Synthase -2
Current Enzyme Inhibition Viruses and Multiple Sclerosis
CNS & Neurological Disorders - Drug Targets